Are some people at increased risk of paracetamol-induced liver injury? A critical review of the literature Thomas M. CaparrottaDaniel J. AntoineJames W. Dear Review Open access 24 October 2017 Pages: 147 - 160
Safety, pharmacokinetics and pharmacodynamics of single rising doses of BI 655064, an antagonistic anti-CD40 antibody in healthy subjects: a potential novel treatment for autoimmune diseases Fredrik N. AlbachFrank WagnerJürgen Steffgen Clinical Trial Open access 10 November 2017 Pages: 161 - 169
Drug safety in pregnancy: the German Embryotox institute Katarina DatheChristof Schaefer Special Article 24 October 2017 Pages: 171 - 179
Pericarditis associated with cytarabine therapy for acute myelocytic leukemia: a case report Xia YangWei LiuKai Hu Special Article 27 October 2017 Pages: 181 - 182
Risk factors for QTc interval prolongation Charlotte P. M. HeemskerkMarieke PereboomMatthijs L. Becker Pharmacodynamics 22 November 2017 Pages: 183 - 191
Comparison of cardiovascular events among treatments for overactive bladder: a Danish nationwide cohort study Andrea V. MargulisJesper HallasAlejandro Arana Pharmacoepidemiology and Prescription 13 November 2017 Pages: 193 - 199
Antidepressants and suicidal behaviour in late life: a prospective population-based study of use patterns in new users aged 75 and above Khedidja HednaKarolina Andersson SundellMargda Waern Pharmacoepidemiology and Prescription Open access 04 November 2017 Pages: 201 - 208
Sociodemographic patterns in pharmacy dispensing of medications for erectile dysfunction in Sweden Pernilla J. BjerkeliShai MulinariJuan Merlo Pharmacoepidemiology and Prescription Open access 03 November 2017 Pages: 209 - 218
Persistence with dimethyl fumarate in relapsing-remitting multiple sclerosis: a population-based cohort study Irene ErikssonThomas CarsMia von Euler Pharmacoepidemiology and Prescription Open access 11 November 2017 Pages: 219 - 226
The use of an electronic clinical rule to discontinue chronically used benzodiazepines and related Z drugs C. Mestres GonzalvoV. MilosevicP. H. M. van der Kuy Pharmacoepidemiology and Prescription 10 November 2017 Pages: 227 - 231
Can clinical practice indicator relating to long-acting benzodiazepine use in the elderly be easily generated in a hospital setting? Badria KadriAntonio TeixeiraPénélope Troude Pharmacoepidemiology and Prescription 16 November 2017 Pages: 233 - 241
Perampanel-associated self-harm ideation after dosage increase Farid KheloufiAnne DefaultJoëlle Micallef Letter to the Editor 11 November 2017 Pages: 243 - 244
Secondary resistance to tolvaptan in two patients with SIAD due to small cell lung cancer A. GarrahyA. M. HannonC. J. Thompson Letter to the Editor 16 November 2017 Pages: 245 - 246
Medication errors with tramadol drops in children Florence MoulisGeneviève DurrieuJean-Louis Montastruc Letter to the Editor 06 November 2017 Pages: 247 - 248
Journals’ TOP guidelines transparency level should be disclosed Rafael Dal-Ré Letter to the Editor 09 November 2017 Pages: 249 - 250
In response to: “Pharmacokinetic modelling of modified acetylcysteine infusion regimens used in the treatment of paracetamol poisoning” Elie HarmoucheMary Ann HowlandMark K Su Letter to the Editor 20 November 2017 Pages: 251 - 251
In reply Anselm WongCornelia B. LandersdorferAndis Graudins Letter to the Editor 16 November 2017 Pages: 253 - 253
Correction to: Metoclopramide role in preventing ileus after cesarean, a clinical trial Jila AgahRoya BaghaniAbolfazl Rad Correction 16 November 2017 Pages: 255 - 255